• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动与肺栓塞和缺血性卒中的病因特异性风险。

Atrial Fibrillation and Cause-Specific Risks of Pulmonary Embolism and Ischemic Stroke.

机构信息

Department of Clinical Medicine, K. G. Jebsen Thrombosis Research and Expertise Center, UiT The Arctic University of Norway, Tromsø, Norway

Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway.

出版信息

J Am Heart Assoc. 2018 Jan 29;7(3):e006502. doi: 10.1161/JAHA.117.006502.

DOI:10.1161/JAHA.117.006502
PMID:29378729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5850231/
Abstract

BACKGROUND

Atrial fibrillation (AF) is a well-established risk factor for ischemic stroke (IS). Emerging evidence also indicates an association between AF and pulmonary embolism (PE). Because IS may potentially mediate the observed risk of PE in AF, we aimed to assess the impact of AF on the cause-specific risks of PE and IS in a large cohort recruited from the general population.

METHODS AND RESULTS

We observed 29 842 participants from 3 surveys of the Tromsø study (inclusion in 1994-1995, 2001-2002, and 2007-2008) to the end of 2012. Incident events of AF, IS, and PE during follow-up were recorded, and information on potential confounders was obtained at baseline. Cox regression models, with AF as a time-dependent variable, were used to calculate cause-specific hazard ratios (HRs) with 95% confidence intervals (CIs) for PE and IS. There were 2067 participants diagnosed as having AF, 296 with PE and 1164 with IS, during a median of 17.6 years of follow-up. The risks of PE (HR, 10.88; 95% CI, 6.23-18.89) and IS (HR, 6.16; 95% CI, 4.47-8.48) were substantially increased during the first 6 months after AF diagnosis, with crude incidence rates of 18.5 per 1000 person-years for PE and 52.8 per 1000 person-years for IS. The risk estimates remained elevated for both PE (HR, 1.72; 95% CI, 1.10-2.71) and IS (HR, 2.45; 95% CI, 2.05-2.92) throughout the study period.

CONCLUSIONS

AF was associated with increased cause-specific risks of both PE and IS. Our findings infer that the risk of PE in AF is not explained by intermediate IS.

摘要

背景

心房颤动(AF)是缺血性卒中(IS)的一个既定危险因素。新出现的证据也表明 AF 与肺栓塞(PE)之间存在关联。由于 IS 可能潜在地介导 AF 中观察到的 PE 风险,我们旨在评估 AF 对来自一般人群的大型队列中 PE 和 IS 的特定原因风险的影响。

方法和结果

我们观察了 Tromsø 研究的 3 项调查(纳入 1994-1995 年、2001-2002 年和 2007-2008 年)中的 29842 名参与者,随访至 2012 年底。记录随访期间的 AF、IS 和 PE 事件,并在基线时获得潜在混杂因素的信息。使用 Cox 回归模型,以 AF 作为时间依赖性变量,计算 PE 和 IS 的特定原因风险比(HR)和 95%置信区间(CI)。在中位随访 17.6 年期间,有 2067 名参与者被诊断为 AF,296 名参与者患 PE,1164 名参与者患 IS。在 AF 诊断后的前 6 个月,PE(HR,10.88;95%CI,6.23-18.89)和 IS(HR,6.16;95%CI,4.47-8.48)的风险显著增加,PE 的粗发病率为 18.5/1000 人年,IS 的粗发病率为 52.8/1000 人年。整个研究期间,PE(HR,1.72;95%CI,1.10-2.71)和 IS(HR,2.45;95%CI,2.05-2.92)的风险估计值仍保持升高。

结论

AF 与 PE 和 IS 的特定原因风险增加相关。我们的研究结果推断,AF 中的 PE 风险不能用中间的 IS 来解释。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bd5/5850231/a777119ccda0/JAH3-7-e006502-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bd5/5850231/56d51566b0c4/JAH3-7-e006502-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bd5/5850231/a777119ccda0/JAH3-7-e006502-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bd5/5850231/56d51566b0c4/JAH3-7-e006502-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bd5/5850231/a777119ccda0/JAH3-7-e006502-g002.jpg

相似文献

1
Atrial Fibrillation and Cause-Specific Risks of Pulmonary Embolism and Ischemic Stroke.心房颤动与肺栓塞和缺血性卒中的病因特异性风险。
J Am Heart Assoc. 2018 Jan 29;7(3):e006502. doi: 10.1161/JAHA.117.006502.
2
Atrial fibrillation and future risk of venous thromboembolism:the Tromsø study.心房颤动与静脉血栓栓塞的未来风险:特罗姆瑟研究。
J Thromb Haemost. 2015 Jan;13(1):10-6. doi: 10.1111/jth.12762. Epub 2014 Nov 22.
3
Atrial fibrillation associated with increased risk of venous thromboembolism. A population-based cohort study.心房颤动与静脉血栓栓塞风险增加相关。一项基于人群的队列研究。
Thromb Haemost. 2015 Jan;113(1):185-92. doi: 10.1160/TH14-05-0405. Epub 2014 Oct 16.
4
Prevalence and Associated Stroke Risk of Human Immunodeficiency Virus-Infected Patients With Atrial Fibrillation - A Nationwide Cohort Study.HIV 感染者合并心房颤动的流行情况及其相关卒中风险:一项全国性队列研究。
Circ J. 2019 Nov 25;83(12):2547-2554. doi: 10.1253/circj.CJ-19-0527. Epub 2019 Oct 17.
5
CHA2DS2-VASc score for ischaemic stroke risk stratification in patients with chronic obstructive pulmonary disease with and without atrial fibrillation: a nationwide cohort study.CHA2DS2-VASc 评分用于伴或不伴心房颤动的慢性阻塞性肺疾病患者的缺血性脑卒中风险分层:一项全国性队列研究。
Europace. 2018 Apr 1;20(4):575-581. doi: 10.1093/europace/eux065.
6
Patients With Ischemic Stroke and Incident Atrial Fibrillation: A Nationwide Cohort Study.缺血性中风与新发房颤患者:一项全国性队列研究。
Stroke. 2015 Sep;46(9):2432-7. doi: 10.1161/STROKEAHA.115.010270. Epub 2015 Aug 6.
7
Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study.缺血性脑卒中与普通人群静脉血栓栓塞风险:特罗姆瑟研究。
J Am Heart Assoc. 2016 Nov 7;5(11):e004311. doi: 10.1161/JAHA.116.004311.
8
Relationship of Preexisting Cardiovascular Comorbidities to Newly Diagnosed Atrial Fibrillation After Ischemic Stroke.缺血性脑卒中后新发心房颤动与预先存在的心血管合并症的关系。
Stroke. 2017 Oct;48(10):2878-2880. doi: 10.1161/STROKEAHA.117.018251. Epub 2017 Sep 1.
9
The Prevalence and Incidence of Atrial Fibrillation in Patients with Acute Pulmonary Embolism.急性肺栓塞患者心房颤动的患病率和发病率
PLoS One. 2016 Mar 1;11(3):e0150448. doi: 10.1371/journal.pone.0150448. eCollection 2016.
10
Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism.新发与预先存在的心房颤动与急性肺栓塞患者结局的相关性。
J Am Heart Assoc. 2021 Sep 7;10(17):e021467. doi: 10.1161/JAHA.121.021467. Epub 2021 Aug 28.

引用本文的文献

1
Pulmonary Embolism in Acute Ischaemic Stroke: Evolving Evidence, Diagnostic Challenges, and a Novel Thromboinflammatory Axis Hypothesis.急性缺血性卒中中的肺栓塞:不断发展的证据、诊断挑战及一种新的血栓炎症轴假说
Int J Mol Sci. 2025 Jul 14;26(14):6733. doi: 10.3390/ijms26146733.
2
Joint effects of atrial fibrillation and prothrombotic genotypes on the risk of venous thromboembolism.心房颤动和血栓形成前基因型对静脉血栓栓塞风险的联合影响。
Res Pract Thromb Haemost. 2025 May 8;9(4):102880. doi: 10.1016/j.rpth.2025.102880. eCollection 2025 May.
3
Clinical Characteristics and Influencing Factors of New-Onset Atrial Fibrillation in Patients with Acute Pulmonary Embolism: A Case-Control Study.

本文引用的文献

1
Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies.传统心血管危险因素与静脉血栓栓塞的关联:前瞻性研究的个体参与者数据荟萃分析
Circulation. 2017 Jan 3;135(1):7-16. doi: 10.1161/CIRCULATIONAHA.116.024507. Epub 2016 Nov 9.
2
Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study.缺血性脑卒中与普通人群静脉血栓栓塞风险:特罗姆瑟研究。
J Am Heart Assoc. 2016 Nov 7;5(11):e004311. doi: 10.1161/JAHA.116.004311.
3
Atherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The Tromsø Study.
急性肺栓塞患者新发心房颤动的临床特征及影响因素:一项病例对照研究
Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296251322779. doi: 10.1177/10760296251322779. Epub 2025 Apr 24.
4
Impact of atrial fibrillation on pulmonary embolism hospitalization: Nationwide analysis.心房颤动对肺栓塞住院治疗的影响:全国性分析。
Am Heart J Plus. 2024 Sep 24;46:100465. doi: 10.1016/j.ahjo.2024.100465. eCollection 2024 Oct.
5
Joint effect of ischemic stroke and obesity on the risk of venous thromboembolism: the Tromsø Study.缺血性中风与肥胖对静脉血栓栓塞风险的联合影响:特罗姆瑟研究
Res Pract Thromb Haemost. 2024 Mar 27;8(3):102392. doi: 10.1016/j.rpth.2024.102392. eCollection 2024 Mar.
6
Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based Study.慢性阻塞性肺疾病急性加重后非致命性心血管事件的时间风险:一项基于人群的研究。
Am J Respir Crit Care Med. 2024 Apr 15;209(8):960-972. doi: 10.1164/rccm.202307-1122OC.
7
Diagnosis and Management of Atrial Fibrillation in Acute Ischemic Stroke in the Setting of Reperfusion Therapy: Insights and Strategies for Optimized Care.再灌注治疗背景下急性缺血性卒中合并心房颤动的诊断与管理:优化治疗的见解与策略
J Cardiovasc Dev Dis. 2023 Nov 12;10(11):458. doi: 10.3390/jcdd10110458.
8
Causal effect of atrial fibrillation on pulmonary embolism: a mendelian randomization study.心房颤动对肺栓塞的因果关系:一项孟德尔随机化研究。
J Thromb Thrombolysis. 2024 Feb;57(2):212-219. doi: 10.1007/s11239-023-02903-w. Epub 2023 Oct 15.
9
Atrial Fibrillation and Reperfusion Therapy in Acute Ischaemic Stroke Patients: Prevalence and Outcomes-A Comprehensive Systematic Review and Meta-Analysis.急性缺血性卒中患者的心房颤动与再灌注治疗:患病率与结局——一项全面的系统评价和荟萃分析
Neurol Int. 2023 Aug 25;15(3):1014-1043. doi: 10.3390/neurolint15030065.
10
Hypertensive heart disease: risk factors, complications and mechanisms.高血压性心脏病:危险因素、并发症及机制
Front Cardiovasc Med. 2023 Jun 5;10:1205475. doi: 10.3389/fcvm.2023.1205475. eCollection 2023.
动脉粥样硬化危险因素与心肌梗死及静脉血栓栓塞风险;固定时间与随时间变化分析。特罗姆瑟研究
PLoS One. 2016 Sep 16;11(9):e0163242. doi: 10.1371/journal.pone.0163242. eCollection 2016.
4
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.2016年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动管理指南。
Europace. 2016 Nov;18(11):1609-1678. doi: 10.1093/europace/euw295. Epub 2016 Aug 27.
5
Atrial fibrillation and risk of stroke: a nationwide cohort study.心房颤动与中风风险:一项全国性队列研究。
Europace. 2016 Nov;18(11):1689-1697. doi: 10.1093/europace/euv401. Epub 2016 Feb 2.
6
Atrial fibrillation and future risk of venous thromboembolism:the Tromsø study.心房颤动与静脉血栓栓塞的未来风险:特罗姆瑟研究。
J Thromb Haemost. 2015 Jan;13(1):10-6. doi: 10.1111/jth.12762. Epub 2014 Nov 22.
7
Atrial fibrillation associated with increased risk of venous thromboembolism. A population-based cohort study.心房颤动与静脉血栓栓塞风险增加相关。一项基于人群的队列研究。
Thromb Haemost. 2015 Jan;113(1):185-92. doi: 10.1160/TH14-05-0405. Epub 2014 Oct 16.
8
Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry.欧洲心房颤动患者临床表现和治疗的地域差异:来自 EURObservational Research Programme Atrial Fibrillation(EORP-AF)试点普通登记处的报告。
Europace. 2015 Feb;17(2):194-206. doi: 10.1093/europace/euu201. Epub 2014 Aug 21.
9
CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation.CHA2DS2-VASc 评分与房颤患者的肺栓塞风险直接相关。
Am J Med. 2014 Jan;127(1):45-52. doi: 10.1016/j.amjmed.2013.10.004. Epub 2013 Oct 15.
10
Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.全球心房颤动流行病学:2010 年全球疾病负担研究。
Circulation. 2014 Feb 25;129(8):837-47. doi: 10.1161/CIRCULATIONAHA.113.005119. Epub 2013 Dec 17.